Quang My Vu, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1702 Auburn Way N Ste A, Auburn, WA 98002 Phone: 253-804-9616 Fax: 253-804-9622 |
Matthew Berg, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17500 Se 392nd St, Auburn, WA 98092 Phone: 253-333-3619 Fax: 253-333-6853 |
Feras Rabi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 762 Supermall Way, Auburn, WA 98001 Phone: 253-735-0708 |
Dr. Sahid Mohamed Sahid Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 High School Rd Ne, Bainbridge Is, WA 98110 Phone: 206-842-4065 |
Ms. Heidi I Sampson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 253 High School Rd Ne, Bainbridge Island, WA 98110 Phone: 206-842-0127 Fax: 206-780-0731 |
Lindsay Lee Holmson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 High School Rd Ne, Bainbridge Island, WA 98110 Phone: 206-842-4065 |
Melanie Anne Solvie Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 253 High School Rd Ne, Bainbridge Island, WA 98110 Phone: 206-842-0127 Fax: 206-780-0731 |
Stacy Elizabeth Johnson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 High School Rd Ne, Bainbridge Island, WA 98110 Phone: 206-842-4065 Fax: 206-780-2781 |
Mr. Justin D Ausmeier, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 High School Rd Ne, Bainbridge Island, WA 98110 Phone: 206-842-4065 Fax: 206-780-2781 |
Christine Mcguire, R. PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 253 High School Rd Ne, Bainbridge Island, WA 98110 Phone: 206-842-0127 Fax: 206-780-0731 |
Vicki Runquist Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 1344 Wintergreen Ln Ne, Bainbridge Island, WA 98110 Phone: 206-842-5632 Fax: 206-842-5992 |
Mrs. Karin Nina Schmugge, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 253 High School Rd Ne, Bainbridge Island, WA 98110 Phone: 206-842-7197 |
Miss Mallory Anne Farrar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8191 Ne Selfors Ln, Bainbridge Island, WA 98110 Phone: 206-850-7914 |
Stewart Umbela, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1315 Wintergreen Ln Ne, Bainbridge Island, WA 98110 Phone: 206-317-8521 |
Mr. Mark Stuhrman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 Nw 12th Ave, Battle Ground, WA 98604 Phone: 360-666-5133 Fax: 360-666-5127 |
Vitaliy Bejan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 W Main St, Battle Ground, WA 98604 Phone: 360-687-5133 |
Ma Jerrylinn Ocampo Tanjutco Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 W Main St, Battle Ground, WA 98604 Phone: 360-687-5136 Fax: 360-687-5186 |
Amy E Delia, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 W Main St, Battle Ground, WA 98604 Phone: 360-687-5186 |
Dr. Dori Ann Miller Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17513 Ne 110th Ave, Battle Ground, WA 98604 Phone: 503-949-2591 |
Hollie Kristin Williams, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 Nw 12th Ave, Battle Ground, WA 98604 Phone: 360-666-5133 Fax: 360-666-5127 |
News Archive
Allergan, Inc. ("Allergan" or the "Company") today acknowledged that Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") have made a second revised, unsolicited proposal to acquire all of the outstanding shares of the Company for a combination of 0.83 of Valeant common shares, $72.00 in cash per share of common stock of the Company, and a Contingent Value Right (CVR) related to DARPinĀ® sales (the "Re-Revised Proposal").
Maintaining a healthy diet may help prevent kidney disease, according to an analysis of published studies. The findings appear in an upcoming issue of CJASN.
New data show that in patients whose melanoma (BRAF V600 mutation-positive) has spread (metastasised) to the brain, Zelboraf (vemurafenib) extends life expectancy by over six months compared to chemotherapy.1 These results are welcome news for patients suffering from metastatic melanoma, as up to half of these patients are diagnosed with brain metastases with many given less than six months to live.1
Researchers are actively cutting the time and cost it normally takes to develop radiopharmaceuticals by taking advantage of "Exploratory Investigational New Drug" (ExpIND), an FDA-sanctioned procedure that enhances post-discovery drug development while observing scientific and patient safety standards.
Mylan Laboratories has announced that the U.S. District Court for the District of Columbia has extended the deadlines pertaining to Mylan's request for a temporary restraining order in its lawsuit seeking to stop the U.S. Food and Drug Administration (FDA) from approving any other Amlodipine Besylate abbreviated new drug applications (ANDAs).
› Verified 9 days ago